<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05125796</url>
  </required_header>
  <id_info>
    <org_study_id>2019-5-1</org_study_id>
    <nct_id>NCT05125796</nct_id>
  </id_info>
  <brief_title>Analgesic Use for Pain Relief in Scorpion Sting</brief_title>
  <official_title>Comparison of iv Paracetamol, iv Dexketoprofen and Topical Lidocaine in Scorpion Sting: a Placebo Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Adiyaman University Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Adiyaman University Research Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In scorpion stings, patients mostly apply with the complaint of pain. Emergency physicians&#xD;
      need to relieve this pain quickly.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Aim: In this study, the analgesic efficacy of intravenous (IV) paracetamol, IV dexketoprofen&#xD;
      trometamol and topical lidocaine will be compared in patients presenting with pain after&#xD;
      scorpion sting.&#xD;
&#xD;
      Methods: This study is a double-blind, randomized, placebo-controlled study conducted in a&#xD;
      tertiary emergency department. Adult patients who applied to the study with no systemic&#xD;
      findings after scorpion sting and especially with pain will be randomly assigned to one of 4&#xD;
      groups: IV paracetamol, IV dexketoprofen trometamol, topical lidocaine or placebo. In order&#xD;
      to determine the intensity of pain, Visual Analog Pain Score (VAS) will be measured at the&#xD;
      time of admission to the emergency department, at the 30th minute and at the 60th minute.&#xD;
      Afterwards, the VAS score changes between the groups will be compared.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 1, 2020</start_date>
  <completion_date type="Actual">October 1, 2021</completion_date>
  <primary_completion_date type="Actual">October 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change of the intensity of pain</measure>
    <time_frame>15 minutes and 30 minutes after the study drug administered</time_frame>
    <description>Pain intense will be measured by 100 mm visual analog scale (Zero; no pain and 100 mm; the worst pain) after 15th and 30th minutes later after the study drug administered</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adverse events</measure>
    <time_frame>30 minutes after the study drug administered</time_frame>
    <description>30 minutes after the study drug administered</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>need to rescue medication</measure>
    <time_frame>30 minutes after the study drug administered</time_frame>
    <description>30 minutes after the study drug administered</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">106</enrollment>
  <condition>Scorpion Stings</condition>
  <arm_group>
    <arm_group_label>paracetamol</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>1000 mg intravenous paracetamol</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dexketoprofen Trometamol</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>50 mg intravenous Dexketoprofen Trometamol</description>
  </arm_group>
  <arm_group>
    <arm_group_label>topical lidocaine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>%5 lidocaine 5 gr topical</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>100 mL intravenous normal saline+ placebo topical pomade</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>paracetamol</intervention_name>
    <description>1000 mg intravenous paracetamol in 100 mL normal saline</description>
    <arm_group_label>Dexketoprofen Trometamol</arm_group_label>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_label>topical lidocaine</arm_group_label>
    <other_name>Paracerol (paracetamol)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexketoprofen Trometamol</intervention_name>
    <description>50 mg intravenous dexketoprofen Trometamol in 100 mL normal saline</description>
    <arm_group_label>paracetamol</arm_group_label>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_label>topical lidocaine</arm_group_label>
    <other_name>Revafen(Dexketoprofen Trometamol)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine topical</intervention_name>
    <description>5 gr of 5% topical lidocaine</description>
    <arm_group_label>Dexketoprofen Trometamol</arm_group_label>
    <arm_group_label>paracetamol</arm_group_label>
    <arm_group_label>placebo</arm_group_label>
    <other_name>Anestol pomade(lidocaine)</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients aged 18 and over with scorpion sting with pain who met the diagnostic&#xD;
             criteria of Grade 1.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients who denied to give informed consent, patients taking analgesic treatment (ice&#xD;
             application or drugs etc.) in the last 6 hours, Patients with any symptoms and&#xD;
             findings of systemic toxicity of scorpion sting, pregnant women, hemodynamically&#xD;
             unstable patients, patients known allergy to drugs of the study.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Umut Gülaçtı</last_name>
    <role>Principal Investigator</role>
    <affiliation>Adiyaman University of Medical Faculty</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Adiyaman University Research Hospital</name>
      <address>
        <city>Adıyaman</city>
        <state>Central</state>
        <zip>02000</zip>
        <country>Turkey</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>November 2, 2021</study_first_submitted>
  <study_first_submitted_qc>November 8, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 18, 2021</study_first_posted>
  <last_update_submitted>November 8, 2021</last_update_submitted>
  <last_update_submitted_qc>November 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Adiyaman University Research Hospital</investigator_affiliation>
    <investigator_full_name>Umut Gulacti</investigator_full_name>
    <investigator_title>Adiyaman University Medical Faculty of Research and Training Hospital</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bites and Stings</mesh_term>
    <mesh_term>Scorpion Stings</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acetaminophen</mesh_term>
    <mesh_term>Dexketoprofen trometamol</mesh_term>
    <mesh_term>Ketoprofen</mesh_term>
    <mesh_term>Lidocaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

